Dal Pan GJ - Search Results

1

Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.

Maro JC, Brown JS, Dal Pan GJ, Kulldorff M. Maro JC, et al. Among authors: dal pan gj. Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):839-48. doi: 10.1002/pds.3618. Epub 2014 Apr 3. Pharmacoepidemiol Drug Saf. 2014. PMID: 24700557 Free PMC article.

2

Assessment of the Impact of Mandated Postmarketing Pediatric-Focused Safety Reviews on Safety-Related Regulatory Actions 2013-2019.

Mohamoud M, Cheng C, Ryan D, Kim I, Wu E, Muñoz M, Kortepeter C, Pinnow E, Dal Pan G. Mohamoud M, et al. Clin Pharmacol Ther. 2023 Jun;113(6):1368-1377. doi: 10.1002/cpt.2900. Epub 2023 Apr 28. Clin Pharmacol Ther. 2023. PMID: 37021630

3

Outpatient use of cardiovascular drugs during pregnancy.

Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Dal Pan GJ, Scott PE, Platt R. Andrade SE, et al. Among authors: dal pan gj. Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):240-7. doi: 10.1002/pds.1550. Pharmacoepidemiol Drug Saf. 2008. PMID: 18200619

4

Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.

Brajovic S, Piazza-Hepp T, Swartz L, Dal Pan G. Brajovic S, et al. Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):565-70; discussion 571-2. doi: 10.1002/pds.3223. Epub 2012 Feb 22. Pharmacoepidemiol Drug Saf. 2012. PMID: 22359404 Review.

5

Orphan therapies: making best use of postmarket data.

Maro JC, Brown JS, Dal Pan GJ, Li L. Maro JC, et al. Among authors: dal pan gj. J Gen Intern Med. 2014 Aug;29 Suppl 3(Suppl 3):S745-51. doi: 10.1007/s11606-014-2882-1. J Gen Intern Med. 2014. PMID: 25029972 Free PMC article.

6

Methodological approaches to evaluate the impact of FDA drug safety communications.

Kesselheim AS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, Zhou EH, Seeger JD, Brownstein JS, Woloshin S, Schwartz LM, Toomey T, Dal Pan GJ, Avorn J. Kesselheim AS, et al. Among authors: dal pan gj. Drug Saf. 2015 Jun;38(6):565-75. doi: 10.1007/s40264-015-0291-y. Drug Saf. 2015. PMID: 25968811

7

Patient and Physician Perceptions of Drug Safety Information for Sleep Aids: A Qualitative Study.

Kesselheim AS, McGraw SA, Dejene SZ, Rausch P, Dal Pan GJ, Lappin BM, Zhou EH, Avorn J, Campbell EG. Kesselheim AS, et al. Among authors: dal pan gj. Drug Saf. 2017 Jun;40(6):531-542. doi: 10.1007/s40264-017-0516-3. Drug Saf. 2017. PMID: 28247279

8

Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications.

Kesselheim AS, Donneyong M, Dal Pan GJ, Zhou EH, Avorn J, Schneeweiss S, Seeger JD. Kesselheim AS, et al. Among authors: dal pan gj. Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):712-721. doi: 10.1002/pds.4215. Epub 2017 Apr 27. Pharmacoepidemiol Drug Saf. 2017. PMID: 28449404

9

Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance.

Harinstein L, Kalra D, Kortepeter CM, Muñoz MA, Wu E, Dal Pan GJ. Harinstein L, et al. Among authors: dal pan gj. Drug Saf. 2019 May;42(5):649-655. doi: 10.1007/s40264-018-0759-7. Drug Saf. 2019. PMID: 30569267

10

Graphical Depiction of Longitudinal Study Designs in Health Care Databases.

Schneeweiss S, Rassen JA, Brown JS, Rothman KJ, Happe L, Arlett P, Dal Pan G, Goettsch W, Murk W, Wang SV. Schneeweiss S, et al. Ann Intern Med. 2019 Mar 19;170(6):398-406. doi: 10.7326/M18-3079. Epub 2019 Mar 12. Ann Intern Med. 2019. PMID: 30856654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters